CY1108832T1 - Φαρμακευτικο εμπλαστρο δραστικης ουσιας με περιορισμενα οπτικα διακριτικα χαρακτηριστικα πανω στο δερμα - Google Patents

Φαρμακευτικο εμπλαστρο δραστικης ουσιας με περιορισμενα οπτικα διακριτικα χαρακτηριστικα πανω στο δερμα

Info

Publication number
CY1108832T1
CY1108832T1 CY20091100230T CY091100230T CY1108832T1 CY 1108832 T1 CY1108832 T1 CY 1108832T1 CY 20091100230 T CY20091100230 T CY 20091100230T CY 091100230 T CY091100230 T CY 091100230T CY 1108832 T1 CY1108832 T1 CY 1108832T1
Authority
CY
Cyprus
Prior art keywords
active substance
patch
pharmaceutical
skin
features above
Prior art date
Application number
CY20091100230T
Other languages
Greek (el)
English (en)
Inventor
Stefan Bracht
Original Assignee
Lts Lohmann Therapie-Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33154271&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1108832(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lts Lohmann Therapie-Systeme Ag filed Critical Lts Lohmann Therapie-Systeme Ag
Publication of CY1108832T1 publication Critical patent/CY1108832T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Spectrometry And Color Measurement (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
CY20091100230T 2003-04-17 2009-02-27 Φαρμακευτικο εμπλαστρο δραστικης ουσιας με περιορισμενα οπτικα διακριτικα χαρακτηριστικα πανω στο δερμα CY1108832T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10317692A DE10317692A1 (de) 2003-04-17 2003-04-17 Medizinische Wirkstoffpflaster mit veringerter optischer Auffälligkeit auf der Haut
EP04726478A EP1615628B1 (de) 2003-04-17 2004-04-08 Medizinische wirkstoffpflaster mit verringerter optischer auffälligkeit auf der haut

Publications (1)

Publication Number Publication Date
CY1108832T1 true CY1108832T1 (el) 2014-07-02

Family

ID=33154271

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091100230T CY1108832T1 (el) 2003-04-17 2009-02-27 Φαρμακευτικο εμπλαστρο δραστικης ουσιας με περιορισμενα οπτικα διακριτικα χαρακτηριστικα πανω στο δερμα

Country Status (22)

Country Link
US (3) US10653636B2 (https=)
EP (1) EP1615628B1 (https=)
JP (2) JP5733875B2 (https=)
KR (1) KR101052127B1 (https=)
CN (1) CN100450472C (https=)
AT (1) ATE415954T1 (https=)
AU (1) AU2004229159B2 (https=)
BR (1) BRPI0409889B8 (https=)
CA (1) CA2522962C (https=)
CY (1) CY1108832T1 (https=)
DE (2) DE10317692A1 (https=)
DK (1) DK1615628T3 (https=)
ES (1) ES2320550T3 (https=)
IL (1) IL171399A (https=)
MX (1) MXPA05010935A (https=)
NZ (1) NZ543195A (https=)
PL (1) PL1615628T3 (https=)
PT (1) PT1615628E (https=)
RU (1) RU2336866C2 (https=)
SI (1) SI1615628T1 (https=)
WO (1) WO2004091590A1 (https=)
ZA (1) ZA200507034B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10317692A1 (de) * 2003-04-17 2004-11-11 Lts Lohmann Therapie-Systeme Ag Medizinische Wirkstoffpflaster mit veringerter optischer Auffälligkeit auf der Haut
DE102005010255A1 (de) * 2005-03-07 2006-09-14 Lts Lohmann Therapie-Systeme Ag Faserfreies transdermales therapeutisches System und Verfahren zu seiner Herstellung
CA2618519C (en) 2005-08-12 2016-09-27 Rick B. Yeager System and method for applying a reflectance modifying agent to improve the visual attractiveness of human skin
US8942775B2 (en) 2006-08-14 2015-01-27 Tcms Transparent Beauty Llc Handheld apparatus and method for the automated application of cosmetics and other substances
US8184901B2 (en) 2007-02-12 2012-05-22 Tcms Transparent Beauty Llc System and method for applying a reflectance modifying agent to change a person's appearance based on a digital image
RU2452474C2 (ru) * 2006-12-01 2012-06-10 Нитто Денко Корпорейшн Стабилизированная адгезивная композиция, содержащая донепезил
US20100062045A1 (en) 2006-12-01 2010-03-11 Nitto Denko Corporation Method for suppressing coloring of adhesive prepartion containing donepezil and method for reducing amounts of donepezil-related substances formed
EP2117721B8 (en) 2007-02-12 2012-08-08 YEAGER, Rick B. System and method for applying agent electrostatically to human skin
US10092082B2 (en) 2007-05-29 2018-10-09 Tcms Transparent Beauty Llc Apparatus and method for the precision application of cosmetics
CN102046171B (zh) * 2008-05-30 2013-06-19 日东电工株式会社 经皮吸收制剂
RU2481826C2 (ru) * 2008-05-30 2013-05-20 Нитто Денко Корпорейшн Содержащий донепезил адгезивный препарат и упаковка для него
KR20180018793A (ko) * 2015-06-22 2018-02-21 존슨 앤드 존슨 컨수머 인코포레이티드 피부에 효과를 제공하는 방법
CN113163930B (zh) * 2019-02-28 2024-11-08 松下知识产权经营株式会社 图像处理装置、图像处理方法以及片材

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE7529365U (de) 1976-01-08 Beiersdorf Ag, 2000 Hamburg Wund schnell verband
JPS55111416A (en) * 1979-02-20 1980-08-28 Taisho Pharmaceut Co Ltd Paster
US4594276A (en) * 1984-04-09 1986-06-10 Minnesota Mining And Manufacturing Company Printed, removable body tattoos on a translucent substrate
JPH0739566B2 (ja) 1986-02-21 1995-05-01 積水化学工業株式会社 医療用粘着テープもしくはシートの製造方法
US5004610A (en) * 1988-06-14 1991-04-02 Alza Corporation Subsaturated nicotine transdermal therapeutic system
US5004510A (en) * 1989-01-30 1991-04-02 Panzhihua Iron & Steel Co. Process for manufacturing high strength railroad rails
DE4030465C2 (de) * 1990-09-26 1994-06-01 Ruschke Mona Pflaster
US5120325A (en) * 1991-06-12 1992-06-09 Fleshtones Products Co., Inc. Color-matched sterile adhesive bandages containing melanin-like pigment composition
CA2075517C (en) * 1992-04-01 1997-03-11 John Wick Transdermal patch incorporating a polymer film incorporated with an active agent
US5264219A (en) * 1992-08-07 1993-11-23 Minnesota Mining And Manufacturing Company Transdermal drug delivery backing
JPH07206624A (ja) 1994-01-20 1995-08-08 Shiseido Co Ltd 皮膚外用剤
US5536263A (en) * 1994-03-30 1996-07-16 Lectec Corporation Non-occulusive adhesive patch for applying medication to the skin
DE19519593C1 (de) * 1995-05-29 1996-08-29 Horstmann Michael Transdermales Therapeutisches System mit druckfarbenfreier Identifikation und Verfahren zu seiner Herstellung
BR9709920A (pt) * 1996-06-20 2000-01-11 Lavipharm Sa Dispositivo para tratamento tópico da acne e seu método de manufatura
US6025535A (en) * 1996-10-28 2000-02-15 The Procter & Gamble Company Topsheet for absorbent articles exhibiting improved masking properties
JPH11116470A (ja) * 1997-08-12 1999-04-27 Takeda Chem Ind Ltd イデベノン含有経皮投与製剤
ES2336054T3 (es) 1998-12-18 2010-04-07 Alza Corporation Dispositivo transparente para la administracion transdermica de nicotina.
DE19912623A1 (de) * 1999-03-20 2000-09-28 Lohmann Therapie Syst Lts Verfahren zur Erhöhung der Stabilität bei Lagerung und/oder Anwendung lichtempfindlicher therapeutischer Systeme oder deren Bestandteile
JP4349772B2 (ja) 2000-04-12 2009-10-21 ザ プロクター アンド ギャンブル カンパニー 局所適用に好適な予め成形されたシート貼付具
DE10053375C1 (de) * 2000-10-27 2002-01-24 Lohmann Therapie Syst Lts Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen
US8586079B2 (en) * 2002-06-21 2013-11-19 Graphic Productions Inc. Promotional simulation for transdermal patch sampler
DE10317692A1 (de) * 2003-04-17 2004-11-11 Lts Lohmann Therapie-Systeme Ag Medizinische Wirkstoffpflaster mit veringerter optischer Auffälligkeit auf der Haut

Also Published As

Publication number Publication date
DE10317692A1 (de) 2004-11-11
US10646453B2 (en) 2020-05-12
JP5733875B2 (ja) 2015-06-10
CA2522962C (en) 2011-11-01
KR20050114724A (ko) 2005-12-06
US20070116751A1 (en) 2007-05-24
EP1615628B1 (de) 2008-12-03
DE502004008582D1 (de) 2009-01-15
AU2004229159B2 (en) 2010-01-28
BRPI0409889A (pt) 2006-05-23
ES2320550T3 (es) 2009-05-25
IL171399A (en) 2015-02-26
RU2005129528A (ru) 2006-05-10
BRPI0409889B1 (pt) 2019-12-17
CA2522962A1 (en) 2004-10-28
DK1615628T3 (da) 2009-04-06
ATE415954T1 (de) 2008-12-15
PL1615628T3 (pl) 2009-06-30
JP2012092133A (ja) 2012-05-17
EP1615628A1 (de) 2006-01-18
RU2336866C2 (ru) 2008-10-27
KR101052127B1 (ko) 2011-07-26
ZA200507034B (en) 2006-05-31
US20190160017A1 (en) 2019-05-30
US11426358B2 (en) 2022-08-30
CN1826103A (zh) 2006-08-30
NZ543195A (en) 2009-04-30
JP2006523637A (ja) 2006-10-19
AU2004229159A1 (en) 2004-10-28
BRPI0409889B8 (pt) 2021-05-25
US10653636B2 (en) 2020-05-19
US20200206147A1 (en) 2020-07-02
CN100450472C (zh) 2009-01-14
HK1079455A1 (zh) 2006-04-07
SI1615628T1 (sl) 2009-04-30
MXPA05010935A (es) 2005-11-25
WO2004091590A1 (de) 2004-10-28
PT1615628E (pt) 2009-03-11

Similar Documents

Publication Publication Date Title
CY1108832T1 (el) Φαρμακευτικο εμπλαστρο δραστικης ουσιας με περιορισμενα οπτικα διακριτικα χαρακτηριστικα πανω στο δερμα
BR0215564A (pt) Composições tópicas para a pele e/ou cabelo que contêm uma proteìna hidrolisada
CO2021013251A2 (es) Derivados de insulina sensibles a la glucosa
CL2004000674A1 (es) Sistema terapeutico transdermico que comprende al menos una sustancia activa farmaceutica, al menos un disruptor de la estructura y/o al menos un formador de estructura en una matriz comun.
PT1155692E (pt) Utilizacao de paclitaxel estabilizado com albumina para a preparacao de um farmaco para o tratamento de tumores solidos e o farmaco assim obtido
CY1107284T1 (el) Τσιροτο για την θεραπεια δυσλειτουργιων και διαταραχων της αυξησης των νυχιων
CY1106411T1 (el) Διαδepμικο θepαπευτικο συστημα με fentanyl
BRPI0410503B8 (pt) composição tópica e uso da composição
CO5050297A1 (es) Uso de peg-ifn-alfa y ribavirina para el tratamiento de hepatitis c cronica
CO5040037A1 (es) Ropa medica con areas impresas regionalmente
CL2003002767A1 (es) Composicion oral que comprende una pelicula que contiene un material funcional, en un vehiculo, util para el cuidado oral.
DE60203260D1 (de) Pharmazeutische mischung gegen krebs, die ein 4-chinazolinamin in kombination mit paclitaxel, carboplatin or vinorelbine enthält
AR010348A1 (es) Cetobenzamidas, su utilizacion y composicion farmeceutica que las contienen
BRPI0519242A2 (pt) uso derivados de 1-aminociclohexano para o tratamento de esclerose méltipla, instabilidade emocional e paralisia pseudobulbar
DE602004004817D1 (de) Myo-inositol hexaphosphat zur topischen verwendung
MX9805294A (es) Articulo absorbente desechable que tiene una grafica que se ha hecho coincidir y un proceso para fabricarla.
BR0215404A (pt) processo e dispositivo para reduzir dosagem terapêutica
CY1111902T1 (el) Χρηση ακυλοφωσφοχολινων σε συνδυασμο με αντινεοπλασματικα φαρμακα
AR050621A1 (es) Sistema terapeutico transdermal con una capa adherente procedimiento para el siliconado de una capa de respaldo y empleo de la capa de respaldo
ATE429908T1 (de) Hormonhaltiges transdermales therapeutisches system mit einem wirkstoffreservoir auf der basis von vinylacetat-vinylpyrrolidon-copolymer mit verbesserter kohäsion.
ES2177783T3 (es) Uso de la gabapentina y sus derivados en el tratamiento de mania y desorden bipolar.
KR900013993A (ko) 활성물질의 국소 또는 계통적 투여를 위한 단계적 약물 방출을 나타내는 경피 시스템 및 그 용도
ECSP055823A (es) DERIVADOS DE [6,7-DIHIDRO-5H-IMIDAZO[1,2-a]IMIDAZOL-3-SULFONILAMINO]-PROPIONAMIDA
ES2065634T3 (es) Composicion cosmetica o farmaceutica para el tratamiento de los cabellos y del cuero cabelludo.
HRP20080597T3 (en) Cancer combination therapy comprising azd2171 and zd1839